145 related articles for article (PubMed ID: 23315217)
1. The expression of moesin in astrocytoma: correlation with pathologic grade and poor clinical outcome.
Wu M; Liu DY; Yuan XR; Liu Q; Jiang XJ; Yuan D; Huang J; Li XJ; Yang ZQ
Med Oncol; 2013 Mar; 30(1):372. PubMed ID: 23315217
[TBL] [Abstract][Full Text] [Related]
2. Expression of autocrine motility factor mRNA is a poor prognostic factor in high-grade astrocytoma.
Tanizaki Y; Sato Y; Oka H; Utsuki S; Kondo K; Miyajima Y; Nagashio R; Fujii K
Pathol Int; 2006 Sep; 56(9):510-5. PubMed ID: 16930331
[TBL] [Abstract][Full Text] [Related]
3. ALDH1 expression is correlated with pathologic grade and poor clinical outcome in patients with astrocytoma.
Liu DY; Ren CP; Yuan XR; Zhang LH; Liu J; Liu Q; Yuan J; Yuan D; Jiang XJ
J Clin Neurosci; 2012 Dec; 19(12):1700-5. PubMed ID: 23084350
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of vascular adhesion protein-1 is associated with poor prognosis of astrocytomas.
Kostoro J; Chang SJ; Clark Lai YC; Wu CC; Chai CY; Kwan AL
APMIS; 2016 Jun; 124(6):462-8. PubMed ID: 26935340
[TBL] [Abstract][Full Text] [Related]
5. The role of FilGAP, a Rac-specific Rho-GTPase-activating protein, in tumor progression and behavior of astrocytomas.
Hara A; Hashimura M; Tsutsumi K; Akiya M; Inukai M; Ohta Y; Saegusa M
Cancer Med; 2016 Dec; 5(12):3412-3425. PubMed ID: 27790861
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of astrocyte elevated gene-1 in human astrocytomas.
He Z; He M; Wang C; Xu B; Tong L; He J; Sun B; Wei L; Chu M
Int J Clin Exp Pathol; 2014; 7(8):5038-44. PubMed ID: 25197376
[TBL] [Abstract][Full Text] [Related]
7. SOX4 is overexpressed in diffusely infiltrating astrocytoma and confers poor prognosis.
Li L; Li Q; Chen X; Xu M; Li X; Nie L; Chen N; Gong J; Mao Q; Zhou Q
Neuropathology; 2015 Dec; 35(6):510-7. PubMed ID: 26096696
[TBL] [Abstract][Full Text] [Related]
8. Mitosin and pHH3 predict poorer survival in astrocytomas WHO grades II and III.
Varughese RK; Lind-Landström T; Habberstad AH; Salvesen Ø; Haug CS; Sundstrøm S; Torp SH
J Clin Pathol; 2016 Jan; 69(1):26-34. PubMed ID: 26188054
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-13 receptor alpha 2 as a marker of poorer prognosis in high-grade astrocytomas.
Wanibuchi M; Kataoka-Sasaki Y; Sasaki M; Oka S; Otsuka Y; Yamaguchi M; Ohnishi H; Ohtaki S; Noshiro S; Ookawa S; Mikami T; Mikuni N; Honmou O
J Neurosurg Sci; 2018 Jun; 62(3):239-244. PubMed ID: 28079349
[TBL] [Abstract][Full Text] [Related]
10. High expression of Aurora-B/Aurora and Ipll-like midbody-associated protein (AIM-1) in astrocytomas.
Araki K; Nozaki K; Ueba T; Tatsuka M; Hashimoto N
J Neurooncol; 2004; 67(1-2):53-64. PubMed ID: 15072448
[TBL] [Abstract][Full Text] [Related]
11. Tissue thioredoxin reductase-1 expression in astrocytomas of different grades.
Esen H; Erdi F; Kaya B; Feyzioglu B; Keskin F; Demir LS
J Neurooncol; 2015 Feb; 121(3):451-8. PubMed ID: 25391969
[TBL] [Abstract][Full Text] [Related]
12. Tenascin-C expression relates to clinicopathological features in pilocytic and diffuse astrocytomas.
Maris C; Rorive S; Sandras F; D'Haene N; Sadeghi N; Bièche I; Vidaud M; Decaestecker C; Salmon I
Neuropathol Appl Neurobiol; 2008 Jun; 34(3):316-29. PubMed ID: 17983425
[TBL] [Abstract][Full Text] [Related]
13. High CHI3L1 expression is associated with glioma patient survival.
Steponaitis G; Skiriutė D; Kazlauskas A; Golubickaitė I; Stakaitis R; Tamašauskas A; Vaitkienė P
Diagn Pathol; 2016 Apr; 11():42. PubMed ID: 27121858
[TBL] [Abstract][Full Text] [Related]
14. Grade-specific expression of insulin-like growth factor-binding proteins-2, -3, and -5 in astrocytomas: IGFBP-3 emerges as a strong predictor of survival in patients with newly diagnosed glioblastoma.
Santosh V; Arivazhagan A; Sreekanthreddy P; Srinivasan H; Thota B; Srividya MR; Vrinda M; Sridevi S; Shailaja BC; Samuel C; Prasanna KV; Thennarasu K; Balasubramaniam A; Chandramouli BA; Hegde AS; Somasundaram K; Kondaiah P; Rao MR
Cancer Epidemiol Biomarkers Prev; 2010 Jun; 19(6):1399-408. PubMed ID: 20501753
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of sphingosine kinase-1 expression in human astrocytomas progression and overall patient survival.
Li J; Guan HY; Gong LY; Song LB; Zhang N; Wu J; Yuan J; Zheng YJ; Huang ZS; Li M
Clin Cancer Res; 2008 Nov; 14(21):6996-7003. PubMed ID: 18980995
[TBL] [Abstract][Full Text] [Related]
16. Expression of TNKS1 is correlated with pathologic grade and Wnt/β-catenin pathway in human astrocytomas.
Tang B; Wang J; Fang J; Jiang B; Zhang M; Wang Y; Yang Z
J Clin Neurosci; 2012 Jan; 19(1):139-43. PubMed ID: 22154485
[TBL] [Abstract][Full Text] [Related]
17. EMMPRIN expression positively correlates with WHO grades of astrocytomas and meningiomas.
Tsai WC; Chen Y; Huang LC; Lee HS; Ma HI; Huang SM; Sytwu HK; Hueng DY
J Neurooncol; 2013 Sep; 114(3):281-90. PubMed ID: 23817808
[TBL] [Abstract][Full Text] [Related]
18. RRP22: a novel neural tumor suppressor for astrocytoma.
Chen R; Yang L; Fang J; Huo L; Zhang M; Chen F; Liu J; Wu J; Wang Y
Med Oncol; 2012 Mar; 29(1):332-9. PubMed ID: 21264544
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical expression of cycloxygenase-2 in astrocytoma: correlation with angiogenesis, tumor progression and survival.
El-Sayed M; Taha MM
Turk Neurosurg; 2011 Jan; 21(1):27-35. PubMed ID: 21294088
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of coexistence of abnormal expression of micro-RNA-200b and cyclic adenosine monophosphate-responsive element-binding protein 1 in human astrocytoma.
Zhang JQ; Yao QH; Kuang YQ; Ma Y; Yang LB; Huang HD; Cheng JM; Yang T; Liu EY; Liang L; Fan KX; Zhao K; Xia X; Gu JW
Hum Pathol; 2014 Oct; 45(10):2154-61. PubMed ID: 25033730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]